NASDAQ:RPTP - Raptor Pharmaceutical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$9.00 0.00 (0.00 %)
(As of 10/22/2018 04:00 PM ET)
Previous Close$9.00
Today's Range$9.00 - $9.00
52-Week Range$2.94 - $9.05
VolumeN/A
Average Volume1.42 million shs
Market Capitalization$767.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Raptor Pharmaceutical Corp. (Raptor) is a biopharmaceutical company. The Company is focused on developing and commercializing transformative treatments for people affected by diseases. Its product, PROCYSBI (cysteamine bitartrate) is a delayed-release capsules for the management of nephropathic cystinosis in adults and children of over six years. In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate), is indicated as an orphan medicinal product for the management of nephropathic cystinosis. Its QUINSAIR is a formulation of the antibiotic drug levofloxacin, suitable for inhalation via a nebulizer. It is engaged in developing MP-376 for non-CF bronchiectasis (BE) and nontuberculous mycobacteria (NTM) lung infections. It is also engaged in developing RP105 and RP106 for various diseases.

Receive RPTP News and Ratings via Email

Sign-up to receive the latest news and ratings for RPTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryBiotechnology
SectorN/A
SymbolNASDAQ:RPTP
CUSIP75382F10
Phone+1-415-4086200

Debt

Debt-to-Equity Ratio1.33
Current Ratio3.57
Quick Ratio3.30

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-43.75%
Return on Equity-77.01%
Return on Assets-15.64%

Miscellaneous

Employees158
Outstanding Shares85,310,000
Market Cap$767.76 million

Raptor Pharmaceutical (NASDAQ:RPTP) Frequently Asked Questions

What is Raptor Pharmaceutical's stock symbol?

Raptor Pharmaceutical trades on the NASDAQ under the ticker symbol "RPTP."

How were Raptor Pharmaceutical's earnings last quarter?

Raptor Pharmaceutical Corp (NASDAQ:RPTP) issued its quarterly earnings results on Thursday, August, 4th. The biotechnology company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.18) by $0.02. The biotechnology company had revenue of $32.05 million for the quarter, compared to analyst estimates of $28.52 million. Raptor Pharmaceutical had a negative return on equity of 77.01% and a negative net margin of 43.75%. The company's quarterly revenue was up 37.4% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.17) earnings per share. View Raptor Pharmaceutical's Earnings History.

How do I buy shares of Raptor Pharmaceutical?

Shares of RPTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Raptor Pharmaceutical's stock price today?

One share of RPTP stock can currently be purchased for approximately $9.00.

How big of a company is Raptor Pharmaceutical?

Raptor Pharmaceutical has a market capitalization of $767.76 million. Raptor Pharmaceutical employs 158 workers across the globe.

What is Raptor Pharmaceutical's official website?

The official website for Raptor Pharmaceutical is http://www.horizonpharma.com/.

How can I contact Raptor Pharmaceutical?

Raptor Pharmaceutical's mailing address is 7 Hamilton Lndg Ste 100, NOVATO, CA 94949-8283, United States. The biotechnology company can be reached via phone at +1-415-4086200.


MarketBeat Community Rating for Raptor Pharmaceutical (NASDAQ RPTP)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  216 (Vote Outperform)
Underperform Votes:  232 (Vote Underperform)
Total Votes:  448
MarketBeat's community ratings are surveys of what our community members think about Raptor Pharmaceutical and other stocks. Vote "Outperform" if you believe RPTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/22/2018 by MarketBeat.com Staff

Featured Article: What is a conference call?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel